Brief: Entera Bio Presents Positive Phase 2 6-Month Bone Mineral Density Data For Oral PTH Formulation At Late Breaker ASBMR Conference Session

Entera Bio

06/10/2021 13:34

Oct 6 (Reuters) - Entera Bio Ltd  5DT.F :
    * ENTERA BIO PRESENTS POSITIVE PHASE 2 6-MONTH BONE MINERAL
DENSITY DATA FOR ORAL PTH FORMULATION AT LATE BREAKER ASBMR
CONFERENCE SESSION
    * ENTERA BIO LTD - INCREASES IN LUMBAR SPINE, FEMORAL NECK
AND
TOTAL HIP BMD DEMONSTRATED WITH EB613
    * ENTERA BIO LTD - PIVOTAL PHASE 3 REGISTRATION STUDY
EXPECTED TO
COMMENCE 2022
    * ENTERA BIO LTD - LINEAR DOSE RESPONSES SEEN IN BIOMARKER
AND
BONE MINERAL DENSITY DATA

Source text for Eikon:  ID:nGNXbKHL8Z 
Further company coverage:  5DT.F 

 ((Reuters.Briefs@thomsonreuters.com;))